These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26131459)

  • 21. Germ-line gene therapy: back to basics.
    Juengst ET
    J Med Philos; 1991 Dec; 16(6):587-92. PubMed ID: 1787388
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preparing for genomic medicine].
    Mäkelä T
    Duodecim; 2004; 120(20):2399-404. PubMed ID: 15641508
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic correction using engineered nucleases for gene therapy applications.
    Li HL; Nakano T; Hotta A
    Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.
    Tedesco FS
    Chromosome Res; 2015 Feb; 23(1):135-41. PubMed ID: 25596829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR: taking the shortcut to a healthy genome editing enterprise.
    Papadaki M
    Regen Med; 2016 Apr; 11(3):229-34. PubMed ID: 26965833
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantifying on- and off-target genome editing.
    Hendel A; Fine EJ; Bao G; Porteus MH
    Trends Biotechnol; 2015 Feb; 33(2):132-40. PubMed ID: 25595557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery technologies for genome editing.
    Yin H; Kauffman KJ; Anderson DG
    Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Communicating Biotech Advances: Fiction versus Reality.
    Małyska A; Bolla R; Twardowski T
    Trends Biotechnol; 2018 Feb; 36(2):121-123. PubMed ID: 29174176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Going Germline: Mitochondrial Replacement as a Guide to Genome Editing.
    Adashi EY; Cohen IG
    Cell; 2016 Feb; 164(5):832-5. PubMed ID: 26919419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered CRISPR Systems for Next Generation Gene Therapies.
    Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
    ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond CRISPR: A guide to the many other ways to edit a genome.
    Ledford H
    Nature; 2016 Aug; 536(7615):136-7. PubMed ID: 27510203
    [No Abstract]   [Full Text] [Related]  

  • 32. The CRISPR Conundrum: As Millions of Dollars Flow into Developing the Gene-Editing Tool, Scientists Continue to Discover the Technology's Potential and Pitfalls.
    Bates M
    IEEE Pulse; 2016; 7(2):17-21. PubMed ID: 26978846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo imaging of gene expression:
    Bremer C; Weissleder R
    Acad Radiol; 2001 Jan; 8(1):15-23. PubMed ID: 11201452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The future of gene therapy in the UK.
    Seymour LW
    Trends Biotechnol; 2006 Aug; 24(8):347-9. PubMed ID: 16782218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.
    Hotta A; Yamanaka S
    Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uses and abuses of human gene transfer.
    Anderson WF
    Hum Gene Ther; 1992 Feb; 3(1):1-2. PubMed ID: 1562636
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of chronic wounds: state of the art and future concepts.
    Eming SA; Smola H; Krieg T
    Cells Tissues Organs; 2002; 172(2):105-17. PubMed ID: 12426487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New scenarios for medical science].
    Esposito S
    Infez Med; 2001 Mar; 9(1):5-6. PubMed ID: 12116953
    [No Abstract]   [Full Text] [Related]  

  • 39. Apoptotic genes in cancer therapy.
    Opalka B; Dickopp A; Kirch HC
    Cells Tissues Organs; 2002; 172(2):126-32. PubMed ID: 12426489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.